EPIX Pharmaceuticals
Recent activities involving EPIX Pharmaceuticals announced
Published in Healthcare Mergers, Acquisitions and Ventures Week, April 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at EPIX Pharmaceuticals.
Report 1: EPIX Pharmaceuticals, Inc. (EPIX) announced that the United States Patent and Trademark Office will issue to EPIX patent number 7,153,858, entitled "New Arylpiperazinyl Compounds."
The granted claims of the patent include the class of selective 5-HT1A binding compounds discovered by EPIX, pharmaceutical compositions containing them, and specific compounds, including PRX-00023.
"This patent is the second U.S. patent...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abdominal Pain
New Survey Reveals Women Are Unaware of the Dangers of Surgical Adhesions - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Pricing of Public Stock Offering - ACADIA Pharmaceuticals Inc.
ACADIA Pharmaceuticals Announces Proposed Public Stock Offering - Accuro Healthcare Solutions, Inc.
Accuro Healthcare Solutions Acquires Woodmoor Group - Acrux
Richard Treagus To Join Acrux Board - Adaptis
Adaptis Conquers QNXT Bachelor Certification in Record Time - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
